These nanoparticles offer a range of advantages, including robust physical stability, resilience against environmentally sensitive and unstable drugs, demonstrated in vivo efficacy with strong cytocompatibility, effective penetration of lipid bilayers, and outstanding physical stability, making them a valuable choice for various applications [83]
The EMPA-REG and CANVAS trials showed that the SGLT-2i empagliflozin and SGLT-1/2i canagliflozin reduced the risk of MACE in T2D patients with or at high risk of CVD by 14%, while the SGLT-2i dapagliflozin did not significantly reduce the risk of MACE, possibly due to the difference in population (approximately 60% with no established ASCVD) between previous trials and strict exclusion criteria
doi: 10.1016/S0140-6736(18)31948-2 200 BraunPRHanSHingBNagahamaYGaulLNHeinzmanJTet al
Utilizamos el componente L-Glutathione, tambin conocido como glutatin reducido , en combinacin con la vitamina C para mejorar su biodisponibilidad y absorcin por el organismo